Intellia Therapeutics Inc (NASDAQ:NTLA)

28.91
Delayed Data
As of Jun 22
 -0.60 / -2.03%
Today’s Change
14.40
Today|||52-Week Range
35.99
+50.42%
Year-to-Date

Today’s Trading

Previous close29.51
Today’s open29.37
Day’s range28.46 - 29.96
Volume3,723,329
Average volume (3 months)1,126,076
Market cap$1.1B
Data as of 4:00pm ET, 06/22/2018

Growth & Valuation

Earnings growth (last year)-32.39%
Earnings growth (this year)-7.89%
Earnings growth (next 5 years)--
Revenue growth (last year)+58.49%
P/E ratioNM
Price/Sales26.50
Price/Book3.47

Competitors

 Today’s
change
Today’s
% change
CHRSCoherus BioSciences ...+0.90+5.52%
IMGNImmunoGen Inc+0.47+4.02%
CRSPCRISPR Therapeutics ...-2.36-3.62%
MYOVMyovant Sciences Ltd-0.54-2.15%
Data as of 4:00pm ET, 06/22/2018

Financials

Next reporting dateJuly 31, 2018
EPS forecast (this quarter)-$0.55
Annual revenue (last year)$26.1M
Annual profit (last year)-$67.5M
Net profit margin-258.62%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John M. Leonard
Executive Vice President &
General Counsel
Jose E. Rivera
Corporate headquarters
Cambridge, Massachusetts

Forecasts